SELLAS Life Sciences (SLS) Revenue (2012 - 2022)

SELLAS Life Sciences (SLS) has 7 years of Revenue data on file, last reported at $1.0 million in Q1 2022.

• Revenue for Q1 2022 came in at $1.0 million, down 82.46% year-over-year; the trailing twelve-month figure through Dec 2022 was $1.0 million (down 86.84% YoY), and the FY2022 annual result was $1.0 million, down 86.84% from the prior year.
• Revenue eased to $1.0 million in Q1 2022 per SLS's latest filing, from $1.9 million in the prior quarter.
• Over five years, Revenue peaked at $5.7 million in Q1 2021 and troughed at $1.0 million in Q1 2022.
• A 3-year average of $2.6 million and a median of $1.9 million in 2020 frame the typical range for Revenue.
• On a YoY basis, Revenue climbed as much as 82.46% in 2022 and fell as far as 82.46% in 2022.
• A 3-year view of Revenue shows it stood at $1.9 million in 2020, then changed by 0.0% to $1.9 million in 2021, then sank by 47.37% to $1.0 million in 2022.
• Business Quant data shows SLS's Revenue at $1.0 million in Q1 2022, $1.9 million in Q2 2021, and $5.7 million in Q1 2021.